Matches in Wikidata for { <http://www.wikidata.org/entity/Q91860625> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q91860625 description "article scientifique publié en 2019" @default.
- Q91860625 description "articolo scientifico (pubblicato il 2019)" @default.
- Q91860625 description "artikull shkencor i botuar më 01 shkurt 2019" @default.
- Q91860625 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91860625 description "scientific article published on 01 February 2019" @default.
- Q91860625 description "wetenschappelijk artikel" @default.
- Q91860625 description "наукова стаття, опублікована 1 лютого 2019" @default.
- Q91860625 name "Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study" @default.
- Q91860625 name "Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study" @default.
- Q91860625 name "Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study" @default.
- Q91860625 type Item @default.
- Q91860625 label "Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study" @default.
- Q91860625 label "Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study" @default.
- Q91860625 label "Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study" @default.
- Q91860625 prefLabel "Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study" @default.
- Q91860625 prefLabel "Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study" @default.
- Q91860625 prefLabel "Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study" @default.
- Q91860625 P1476 Q91860625-96EBB2B7-E229-44D5-BD35-B86D0A85C938 @default.
- Q91860625 P2093 Q91860625-20733FA8-CCCD-4196-A4D4-389280B38C93 @default.
- Q91860625 P2093 Q91860625-529BA7B4-1AB4-4CB7-B088-3D40636B90E0 @default.
- Q91860625 P2093 Q91860625-75CC364A-C180-4006-81E8-8E93E09AC66A @default.
- Q91860625 P2093 Q91860625-99A5F079-A58A-4253-BAA7-14AD263F2853 @default.
- Q91860625 P2093 Q91860625-A85CABA9-15F3-4563-B5A9-E6413BFA4514 @default.
- Q91860625 P2093 Q91860625-A9D78219-4E57-438F-87BF-A1FB6D45852D @default.
- Q91860625 P2093 Q91860625-E6E8EB87-8C71-4262-BFBE-0B2067C2C30B @default.
- Q91860625 P304 Q91860625-26D550B6-9708-44E8-A92F-ED5BB8013374 @default.
- Q91860625 P31 Q91860625-94B4830B-5CAF-4EA5-8AEB-5CC0BCFEEFF4 @default.
- Q91860625 P356 Q91860625-D6A9C0BC-B476-4C6D-B417-48B4F23B0E00 @default.
- Q91860625 P433 Q91860625-54658195-211B-4BD5-AB59-3C48805A0611 @default.
- Q91860625 P478 Q91860625-4FA1D169-389A-4183-A162-726026FD65C9 @default.
- Q91860625 P50 Q91860625-01FEEE09-6DD5-4026-A4BB-75647DE3F829 @default.
- Q91860625 P50 Q91860625-CADD260C-DEAF-494F-BA35-D04E0D133DA7 @default.
- Q91860625 P577 Q91860625-34D0634A-5A97-454C-B866-DC434D4EFC84 @default.
- Q91860625 P698 Q91860625-AB03F82C-0570-4816-A566-C640F611D9B6 @default.
- Q91860625 P921 Q91860625-0012A9D6-935B-4436-95F4-BB443E328156 @default.
- Q91860625 P921 Q91860625-5699EBCD-9F3C-4EDA-AB71-C5A1EBEB5430 @default.
- Q91860625 P356 15284336.2019.1608714 @default.
- Q91860625 P698 31303147 @default.
- Q91860625 P1476 "Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study" @default.
- Q91860625 P2093 "Bruce Rashbaum" @default.
- Q91860625 P2093 "Cheryl McDonald" @default.
- Q91860625 P2093 "Cristina Mussini" @default.
- Q91860625 P2093 "Donghan Luo" @default.
- Q91860625 P2093 "Erika Van Landuyt" @default.
- Q91860625 P2093 "John Jezorwski" @default.
- Q91860625 P2093 "Kimberley Brown" @default.
- Q91860625 P304 "24-33" @default.
- Q91860625 P31 Q13442814 @default.
- Q91860625 P356 "10.1080/15284336.2019.1608714" @default.
- Q91860625 P433 "1" @default.
- Q91860625 P478 "20" @default.
- Q91860625 P50 Q60596717 @default.
- Q91860625 P50 Q81616553 @default.
- Q91860625 P577 "2019-02-01T00:00:00Z" @default.
- Q91860625 P698 "31303147" @default.
- Q91860625 P921 Q155954 @default.
- Q91860625 P921 Q422604 @default.